Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study (Q57213847)

From Wikidata

Jump to navigation Jump to search

No description defined

Language	Label	Description	Also known as
English	Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study	No description defined

Statements

scholarly article

0 references

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study (English)

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

electrocardiography

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

R Pfister

1

0 references

R Cairns

2

0 references

E Erdmann

3

0 references

C A Schneider

4

0 references

language of work or name

0 references

publication date

October 2011

0 references

Diabetic Medicine

0 references

28

0 references

10

0 references

1206-12

0 references

The ECG in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhyth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Comm

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Incident heart failure prediction in the elderly: the health ABC heart failure score

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Incidence of and risk factors for bundle branch block in adults older than 40 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Relations among heart failure severity, left ventricular loading conditions, and repolarization length in advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Long-term outcome associated with early repolarization on electrocardiography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03281.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2011.03281.X

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57213847&oldid=1969945106"